Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution Paragangliomas of the head and neck-local control and functional outcomes following stereotactic radiotherapy (2018) Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution Multicenter quality assurance evaluation of MR-guided deep hyperthermia systems (2018) Curto S, Mulder T, Aklan B, Mils O, Schmidt M, Lamprecht U, Peller M, et al. Conference contribution Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Radio(chemo)therapy does differently impact on PD-L1 and PD-L2 expression in human melanoma cell lines (2018) Derer A, Riegel D, Frey B, Fietkau R, Gaipl U Conference contribution Pretreatment vitamin D levels are associated with improved overall survival following combined chemoradiotherapy (2018) Putz F, Distel L, Lettmaier S, Weissmann T, Filimonova I, Fietkau R Conference contribution Mechanism of necrotic Cell Clearance by non-professional Phagocytes (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes are able to generate Cell-in-Cell Structures (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Kinase Inhibitor Palbociclib shows differential Effects upon Irradiation on Normal Tissue and Cancer Cell Lines (2018) Jost T, Proebstle S, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution